Considerations regarding the use of cytokines in active specific immunotherapy of cancer

Vaccine Research

Volumn 5, Issue 1, 1996, Pages 41-52

  Lin, R ^a   Tarr, P E ^a   Jones, T C ^a  

^a Sandoz Pharma Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR VACCINE;

ACTIVE IMMUNIZATION; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNIZATION; DRUG EFFICACY; PRIORITY JOURNAL; TUMOR IMMUNITY;

EID: 0030005405     PISSN: 10567909     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)